Search for: "Anda Pharmaceuticals, Inc"
Results 521 - 540
of 607
Sort by Relevance
|
Sort by Date
15 Apr 2009, 8:56 pm
By Suresh Pillai -- Resolution Announced in Johnson & Johnson Razadyne ® ER Patent Litigation Johnson & Johnson units Janssen LP, Janssen Pharmaceutica NV, and Ortho-McNeil Neurologics have stipulated to a dismissal with prejudice of all claims of patent infringement against KV Pharmaceutical Co., Barr Pharmaceuticals Inc., and Sandoz Inc. with respect to a generic version of Razadyne ® ER. [read post]
9 Apr 2009, 7:52 am
(IP Think Tank) Brazilian public-private partnerships in the pharma industry (IP tango) EU: ECJ to rule on reference on SPC Regulation interpretation from Lithuania in Kirin Amgen, Inc. v Lietuvos Respublikos valstybinis patentų biuras (The SPC Blog) India: Delhi High Court Dasatinib order: Is patent-drug regulatory linkage a necessity? [read post]
27 Mar 2009, 8:00 am
(Intellectual Property Watch) Two final thoughts on big pharma acquisitions (IP finance) Brazil: Patent term cutbacks in Brazil and pharmaceutical pipelines – IP Think Tank podcast 23 March 2009 (IP Think Tank) Brazil: Patent term cutbacks - Lobbying, intellectual property and superior courts (IP Think Tank) Brazil: Patent term extension (PTE) under TRIPs revisited and reviewed by Superior Court of Justice (IP tango) Denmark: Harmonisation in Denmark: Patents covering… [read post]
16 Mar 2009, 8:52 pm
By Suresh Pillai -- Sepracor Settles Xopenex Suit With Barr Last week, Sepracor Inc. and Barr Pharmaceuticals, Inc. [read post]
FTC and California AG Join in Challenging Reverse Payment Settlements in the Pharmaceutical Industry
6 Mar 2009, 7:03 am
Watson Pharm., Inc. et al., 09-cv-00598 (AHM) ("Watson"). [read post]
27 Feb 2009, 5:00 am
Teva Parenteral Medicines Inc. et al. [read post]
24 Feb 2009, 9:43 pm
Food and Drug Administration from approving the Abbreviated New Drug Application (ANDA) filed by Defendant-Appellant Teva Pharmaceuticals USA, Inc. [read post]
24 Feb 2009, 2:22 pm
USA, Inc., No. 2009–1071 (Fed. [read post]
22 Feb 2009, 8:38 pm
By Sherri Oslick --About Court Report: Each week we will report briefly on recently filed biotech and pharma cases, and a few interesting cases will be selected for periodic monitoring.Millennium Pharmaceuticals Inc. et al. v. [read post]
9 Feb 2009, 11:32 pm
(alleged infringers)Eli Lilly's (patent owner) Cymbalta drugAstraZeneca's (patent owner) Crestor drugPenwest Pharmaceuticals (patent owner) Opana ER drugSepracor's (patent owner) Xyzal drugOf Apple and US 7,479,949, see the IPBiz post Obvious? [read post]
30 Jan 2009, 9:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: US: AIPLA urges Federal Circuit not to proscribe patents for biomedical diagnostic tools: Prometheus v Mayo (Inventive Step) (Hal Wegner) (Patently-O) (Holman's Biotech IP Blog) Lovenox (Enoxaparin) – US: Aventis files for certiorari: challenging Federal Circuit’s low standard for intent to deceive in inequitable… [read post]
13 Jan 2009, 8:41 am
Caraco Pharmaceutical: Whether DJ jurisdiction can exist after the patentee has granted an ANDA applicant a covenant not to sue. [read post]
8 Jan 2009, 12:38 pm
On March 31, 2005, one year into the FDA review of the generic manufacturers' ANDA submissions, Defendants Aventis Pharmaceuticals, Inc., Sanofi-Aventis, and Sanofi-Aventi U.S., LLC (collectively "Aventis") filed a Citizen Petition pursuant to Section 505(j) of the Federal Food, Drug, and Cosmetic Act. [read post]
19 Dec 2008, 1:00 pm
$16.8 million for Alphapharm and Mylan: Takeda v Mylan (Patent Baristas) (Patent Docs) Boniva (Ibandronic acid) – US: Apotex challenges validity of Hoffmann-La Roche’s Boniva patent (Law360) Boniva (Ibandronic acid) – US: Orchid Chemicals & Pharmaceuticals and Orgenus Pharma seek declaratory judgment of invalidity and noninfringement in patent infringement suit brought by Hoffmann-La Roche over Boniva (Law360) Cardizem (Diltiazem) – Antitrust,… [read post]
16 Dec 2008, 5:16 am
Sanofi-Synthelabo, Sanofi-Synthelabo, Inc., and Bristol-Myers Squibb Sanofi Pharmaceuticals Holding Partnership (collectively, Sanofi) brought suit under 35 U.S.C. [read post]
11 Dec 2008, 10:30 pm
(now known as IVAX Pharmaceuticals, Inc.) [read post]
5 Dec 2008, 5:31 am
By Mark Chael -- On December 2nd, Mylan, Inc. and Mylan Pharmaceuticals, Inc. announced that they had settled their dispute with Novartis Pharmaceuticals Corp., Novartis Corp., and Novartis International AG over a generic version of Novartis' Femara ® tablets.According to the press release, Femara ® tablets, which are used in the treatment of breast cancer, had U.S. sales of about $470 million for the 12 months ending September 30, 2008.… [read post]
24 Nov 2008, 2:09 am
Teva Pharmaceuticals USA, Inc. et al.1:08-cv-06659; filed November 20, 2008 in the Northern District of IllinoisInfringement of U.S. [read post]
18 Nov 2008, 10:40 pm
Lilly also sued Sandoz Inc., Impax Laboratories Inc. and Cobalt Laboratories Inc. in separate lawsuits for seeking generic approval for Cymbalta tablets. [read post]
13 Nov 2008, 5:27 pm
The Supreme Court's 2004 decision in Verizon Communications Inc. v. [read post]
